HIV-1 Tat and Immune Dysregulation in AIDS Pathogenesis: A Therapeutic Target

被引：11

作者：

Chiozzini, Chiara ^{[1
]}

Toschi, Elena ^{[2
]}

机构：

[1] Ist Super Sanita, Natl AIDS Ctr, I-00161 Rome, Italy

[2] Ist Super Sanita, Dept Hematol Oncol & Mol Med, I-00161 Rome, Italy

来源：

CURRENT DRUG TARGETS | 2016年 / 17卷 / 01期

关键词：

AIDS pathogenesis; immune dysregulation; HIV-1; Tat; therapy; vaccine; HUMAN-IMMUNODEFICIENCY-VIRUS; NF-KAPPA-B; RECEPTOR-RELATED PROTEIN; 2ND CODING EXON; T-CELLS; KAPOSIS-SARCOMA; DENDRITIC CELLS; GROWTH-FACTOR; GENE-THERAPY; IN-VIVO;

D O I：

10.2174/1389450116666150825110658

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

The HIV-1 transactivator Tat protein plays a key role in AIDS pathogenesis. Besides the Tat role as activator of HIV-1 transcription, it exerts several important functions on infected and uninfected cells. In fact, HIV-1 Tat is released by infected cells and is taken up by neighboring cells. In this way it regulates expression of viral and cellular genes and it modulates several cellular pathways leading to HIV-1 infection spreading and immune dysregulation. So far, Tat protein and the cellular pathways targeted by Tat may represent potential targets for new anti-HIV therapeutic approaches and vaccine development against AIDS.

引用

页码：33 / 45

页数：13

共 160 条

[1] The angiogenesis induced by HIV-1 Tat protein is mediated by the Flk-1/KDR receptor on vascular endothelial cells [J].

Albini, A ;

Soldi, R ;

Giunciuglio, D ;

Giraudo, E ;

Benelli, R ;

Primo, L ;

Noonan, D ;

Salio, M ;

Camussi, G ;

Rockl, W ;

Bussolino, F .

NATURE MEDICINE, 1996, 2 (12) :1371-1375

[2] A phase I/IIa immunotherapy trial of HIV-1-infected patients with Tat, Rev and Nef expressing dendritic cells followed by treatment interruption [J].

Allard, Sabine D. ;

De Keersmaecker, Brenda ;

de Goede, Anna L. ;

Verschuren, Esther J. ;

Koetsveld, Jeanette ;

Reedijk, Mariska L. ;

Wylock, Carolien ;

De Bel, Annelies V. ;

Vandeloo, Judith ;

Pistoor, Frank ;

Heirman, Carlo ;

Beyer, Walter E. P. ;

Eilers, Paul H. C. ;

Corthals, Jurgen ;

Padmos, Iman ;

Thielemans, Kris ;

Osterhaus, Albert D. M. E. ;

Lacor, Patrick ;

van der Ende, Marchina E. ;

Aerts, Joeri L. ;

van Baalen, Carel A. ;

Gruters, Rob A. .

CLINICAL IMMUNOLOGY, 2012, 142 (03) :252-268

[3] Tat-specific cytotoxic T lymphocytes select for SIV escape variants during resolution of primary viraemia [J].

Allen, TM ;

O'Connor, DH ;

Jing, PC ;

Dzuris, JL ;

Mothé, BR ;

Vogel, TU ;

Dunphy, E ;

Liebl, ME ;

Emerson, C ;

Wilson, N ;

Kunstman, KJ ;

Wang, XC ;

Allison, DB ;

Hughes, AL ;

Desrosiers, RC ;

Altman, JD ;

Wolinsky, SM ;

Sette, A ;

Watkins, DI .

NATURE, 2000, 407 (6802) :386-390

[4] HIV-1 Tat induces the expression of the interleukin-6 (IL6) gene by binding to the IL6 leader RNA and by interacting with CAAT enhancer-binding protein beta (NF-IL6) transcription factors [J].

Ambrosino, C ;

Ruocco, MR ;

Chen, XN ;

Mallardo, M ;

Baudi, F ;

Trematerra, S ;

Quinto, I ;

Venuta, S ;

Scala, G .

JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (23) :14883-14892

[5] The secretory route of the leaderless protein interleukin 1β involves exocytosis of endolysosome-related vesicles [J].

Andrei, C ;

Dazzi, C ;

Lotti, L ;

Torrisi, MR ;

Chimini, G ;

Rubartelli, A .

MOLECULAR BIOLOGY OF THE CELL, 1999, 10 (05) :1463-1475

[6] HIV-1 Tat enhances Kaposi sarcoma-associated herpesvirus (KSHV) infectivity [J].

Aoki, Y ;

Tosato, G .

BLOOD, 2004, 104 (03) :810-814

[7] Novel Biopanning Strategy To Identify Epitopes Associated with Vaccine Protection [J].

Bachler, Barbara C. ;

Humbert, Michael ;

Palikuqi, Brisa ;

Siddappa, Nagadenahalli B. ;

Lakhashe, Samir K. ;

Rasmussen, Robert A. ;

Ruprecht, Ruth M. .

JOURNAL OF VIROLOGY, 2013, 87 (08) :4403-4416

[8] Tat protein of human immunodeficiency virus type 1 induces interleukin-10 in human peripheral blood monocytes: Implication of protein kinase C-dependent pathway [J].

Badou, A ;

Bennasser, Y ;

Moreau, M ;

Leclerc, C ;

Benkirane, M ;

Bahraoui, E .

JOURNAL OF VIROLOGY, 2000, 74 (22) :10551-10562

[9]

Barillari G, 1999, BLOOD, V94, P663

[10] THE TAT PROTEIN OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1, A GROWTH-FACTOR FOR AIDS KAPOSI-SARCOMA AND CYTOKINE-ACTIVATED VASCULAR CELLS, INDUCES ADHESION OF THE SAME CELL-TYPES BY USING INTEGRIN RECEPTORS RECOGNIZING THE RGD AMINO-ACID-SEQUENCE [J].

BARILLARI, G ;

GENDELMAN, R ;

GALLO, RC ;

ENSOLI, B .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (17) :7941-7945

← 1 2 3 4 5 6 7 8 9 10 →